Michael Liggett - Net Worth and Insider Trading
Michael Liggett Net Worth
The estimated net worth of Michael Liggett is at least $8,500 dollars as of 2025-01-09. Michael Liggett is the Director of Rakovina Therapeutics Inc and owns about 50,000 shares of Rakovina Therapeutics Inc (TSXV:RKV) stock worth over $8,500. Details can be seen in Michael Liggett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Liggett has not made any transactions after 2024-12-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Liggett
Michael Liggett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Liggett owns 1 companies in total, including Rakovina Therapeutics Inc (TSXV:RKV) .
Click here to see the complete history of Michael Liggett’s form 4 insider trades.
Insider Ownership Summary of Michael Liggett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSXV:RKV | Rakovina Therapeutics Inc | 2024-12-19 | Director |
Michael Liggett Latest Holdings Summary
Michael Liggett currently owns a total of 1 stock. Michael Liggett owns 50,000 shares of Rakovina Therapeutics Inc (TSXV:RKV) as of December 19, 2024, with a value of $8,500.
Latest Holdings of Michael Liggett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSXV:RKV | Rakovina Therapeutics Inc | 2024-12-19 | 50,000 | 0.17 | 8,500 |
Holding Weightings of Michael Liggett
Michael Liggett Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Liggett has made a total of 1 transactions in Rakovina Therapeutics Inc (TSXV:RKV) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rakovina Therapeutics Inc is the acquisition of 50,000 shares on December 19, 2024, which cost Michael Liggett around $7,500.
Insider Trading History of Michael Liggett
- 1
Michael Liggett Trading Performance
Michael Liggett Ownership Network
Michael Liggett Owned Company Details
What does Rakovina Therapeutics Inc do?
Who are the key executives at Rakovina Therapeutics Inc?
Michael Liggett is the Director of Rakovina Therapeutics Inc. Other key executives at Rakovina Therapeutics Inc include Director & Senior Officer Alfredo De Lucrezia , Senior Officer Jeffrey Bacha , and Senior Officer Mads Daugaard .
Rakovina Therapeutics Inc (TSXV:RKV) Insider Trades Summary
Over the past 18 months, Michael Liggett made 1 insider transaction in Rakovina Therapeutics Inc (TSXV:RKV) with a net purchase of 50,000. Other recent insider transactions involving Rakovina Therapeutics Inc (TSXV:RKV) include a net purchase of 170,000 shares made by Jeffrey Bacha , a net sale of 25,357 shares made by Alfredo De Lucrezia , and a net purchase of 25,000 shares made by Mads Daugaard .
In summary, during the past 3 months, insiders sold 132,500 shares of Rakovina Therapeutics Inc (TSXV:RKV) in total and bought 50,000 shares, with a net sale of 82,500 shares. During the past 18 months, 132,500 shares of Rakovina Therapeutics Inc (TSXV:RKV) were sold and 352,143 shares were bought by its insiders, resulting in a net purchase of 219,643 shares.
Rakovina Therapeutics Inc (TSXV:RKV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rakovina Therapeutics Inc Insider Transactions
Michael Liggett Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Liggett. Currently GuruFocus does not have mailing address information for Michael Liggett.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
